These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 8181029)
1. The complement system in myocardial ischaemia/reperfusion injury. Kilgore KS; Friedrichs GS; Homeister JW; Lucchesi BR Cardiovasc Res; 1994 Apr; 28(4):437-44. PubMed ID: 8181029 [No Abstract] [Full Text] [Related]
2. Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium. Väkevä A; Morgan BP; Tikkanen I; Helin K; Laurila P; Meri S Am J Pathol; 1994 Jun; 144(6):1357-68. PubMed ID: 7515561 [TBL] [Abstract][Full Text] [Related]
3. Complement activation and inhibition in myocardial ischemia and reperfusion injury. Homeister JW; Lucchesi BR Annu Rev Pharmacol Toxicol; 1994; 34():17-40. PubMed ID: 8042849 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of complement inhibitors in myocardial ischaemia. Lucchesi BR; Tanhehco EJ Expert Opin Investig Drugs; 2000 May; 9(5):975-91. PubMed ID: 11060721 [TBL] [Abstract][Full Text] [Related]
5. The future use of complement inhibitors for the treatment of neurological diseases. McGeer EG; McGeer PL Drugs; 1998 Jun; 55(6):739-46. PubMed ID: 9617589 [TBL] [Abstract][Full Text] [Related]
6. A blockade of complement activation prevents rapid intestinal ischaemia-reperfusion injury by modulating mucosal mast cell degranulation in rats. Kimura T; Andoh A; Fujiyama Y; Saotome T; Bamba T Clin Exp Immunol; 1998 Mar; 111(3):484-90. PubMed ID: 9528887 [TBL] [Abstract][Full Text] [Related]
7. Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardium. Weisman HF; Bartow T; Leppo MK; Boyle MP; Marsh HC; Carson GR; Roux KH; Weisfeldt ML; Fearon DT Trans Assoc Am Physicians; 1990; 103():64-72. PubMed ID: 2132543 [TBL] [Abstract][Full Text] [Related]
8. No prominent role for terminal complement activation in the early myocardial reperfusion phase following cardiac surgery. Kortekaas KA; van der Pol P; Lindeman JH; Baan CC; van Kooten C; Klautz RJ Eur J Cardiothorac Surg; 2012 May; 41(5):e117-25. PubMed ID: 22408044 [TBL] [Abstract][Full Text] [Related]
9. Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: a comparison between C6-competent and C6-deficient rabbits. Ito W; Schäfer HJ; Bhakdi S; Klask R; Hansen S; Schaarschmidt S; Schofer J; Hugo F; Hamdoch T; Mathey D Cardiovasc Res; 1996 Aug; 32(2):294-305. PubMed ID: 8796116 [TBL] [Abstract][Full Text] [Related]
10. Complement and its implications in cardiac ischemia/reperfusion: strategies to inhibit complement. Monsinjon T; Richard V; Fontaine M Fundam Clin Pharmacol; 2001 Oct; 15(5):293-306. PubMed ID: 11903498 [TBL] [Abstract][Full Text] [Related]
11. [Complement inhibition: a new therapeutic modality?]. Porcel JM Med Clin (Barc); 1995 Nov; 105(18):700-2. PubMed ID: 8538252 [No Abstract] [Full Text] [Related]
19. Physiology and pathophysiology of complement: progress and trends. Morgan BP Crit Rev Clin Lab Sci; 1995; 32(3):265-98. PubMed ID: 7495498 [TBL] [Abstract][Full Text] [Related]
20. Complement in ischemia reperfusion injury. Riedemann NC; Ward PA Am J Pathol; 2003 Feb; 162(2):363-7. PubMed ID: 12547694 [No Abstract] [Full Text] [Related] [Next] [New Search]